Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026)
Intuitive Surgical (ISRG) recorded quarterly Cash from Investing Activities of -$914.5 million in Q1 2026, down 336.72% quarter-over-quarter from -$209.4 million in Q4 2025, and down 528.34% on a YoY basis from $213.5 million in Q1 2025.
Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Intuitive Surgical's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$914.5 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 528.34% year-over-year to -$914.5 million; the TTM figure through Mar 2026 stood at -$462.2 million (up 84.23% YoY), while the FY2025 annual figure was $665.8 million, up 120.34% from the prior year.
- Cash from Investing Activities was -$914.5 million for Q1 2026 at Intuitive Surgical, down from -$209.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $574.8 million in Q4 2022 to a low of -$1.4 billion in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$147.7 million across 5 years, with a median of -$128.5 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities surged 366.93% in 2023, then slumped 528.34% in 2026.
- A 5-year view of Cash from Investing Activities shows it stood at $574.8 million in 2022, then plunged by 281.66% to -$1.0 billion in 2023, then declined by 21.07% to -$1.3 billion in 2024, then soared by 83.44% to -$209.4 million in 2025, then sank by 336.72% to -$914.5 million in 2026.
- The last three Cash from Investing Activities figures came in at -$914.5 million (Q1 2026), -$209.4 million (Q4 2025), and $401.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -65.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -914.50 Mn |
| Mar 31, 2026 | -914.50 Mn |
| Dec 31, 2025 | -209.40 Mn |
| Dec 31, 2025 | -209.40 Mn |
| Sep 30, 2025 | 401.00 Mn |
| Sep 30, 2025 | 401.00 Mn |
| Jun 30, 2025 | 260.70 Mn |
| Jun 30, 2025 | 260.70 Mn |
| Mar 31, 2025 | 213.50 Mn |
| Mar 31, 2025 | 213.50 Mn |
| Dec 31, 2024 | -1.26 Bn |
| Dec 31, 2024 | -1.26 Bn |
| Sep 30, 2024 | -1.41 Bn |
| Sep 30, 2024 | -1.41 Bn |
| Jun 30, 2024 | -467.10 Mn |
| Jun 30, 2024 | -467.10 Mn |
| Mar 31, 2024 | -128.50 Mn |
| Mar 31, 2024 | -128.50 Mn |
| Dec 31, 2023 | -1.04 Bn |
| Dec 31, 2023 | -1.04 Bn |